Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.2337/dc09-0523. Epub 2009 Jul 8.
Affiliations
- PMID: 19587364
- PMCID: PMC2732165
- DOI: 10.2337/dc09-0523
Randomized Controlled Trial
Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program
Leigh Perreault et al. Diabetes Care. 2009 Sep.
Abstract
Objective: Participants in the Diabetes Prevention Program (DPP) randomized to intensive lifestyle modification (ILS) or metformin had a significantly reduced incidence of diabetes compared with those randomized to placebo, yet most were still at risk because they had pre-diabetes. We explored the effect of baseline characteristics, weight change, ILS, and metformin on regression from pre-diabetes to the lowest-risk state of normal glucose regulation (NGR) defined by American Diabetes Association criteria.
Research design and methods: The DPP was a prospective randomized trial. Cox proportional hazards modeling was used to identify predictors of regression from pre-diabetes to NGR over 3 years of follow-up.
Results: Lower baseline fasting (hazard ratio 1.52, P < 0.01) and 2-h (1.24, P < 0.01) glucose predicted regression to NGR, as did younger age (1.07, P < 0.01) and greater insulin secretion (1.09, P = 0.04). ILS (2.05, P < 0.01) and weight loss (1.34, P < 0.01) had significant and independent effects on regression. A nonsignificant trend for regression was also observed for metformin (1.25, P = 0.06), male sex (1.17, P = 0.08), and insulin sensitivity (1.07, P = 0.09). In those entering the study with both impaired fasting glucose (IFG) and impaired glucose tolerance (IGT), male sex and insulin sensitivity predicted regression to isolated IFG, whereas ILS, metformin, female sex, and greater insulin secretion predicted regression to isolated IGT.
Conclusions: Insulin secretion, and other biologic processes retained with younger age, are key in restoring NGR in people with pre-diabetes. However, NGR may also be attained through weight loss and additional aspects of ILS.
Figures
Figure 1
Flowchart for primary data analysis illustrating handling of the data from years 1 to 3. IFG, fasting glucose = 5.6–6.9 mmol/l; IGT, 2-h glucose = 7.8–11.1 mmol/l; NGR, fasting glucose <5.6 mmol/l; and 2-h glucose <7.8 mmol/l. Data “not included” were censored from subsequent analyses due to regression to NGR (in year prior), isolated IFG or IGT, progression to diabetes, or missing data.
Figure 2
Cumulative incidence of NGR according to treatment group, adjusted for baseline age, sex, ethnicity, weight, fasting and 2-h glucose concentrations, as well as insulin sensitivity (1/fasting insulin) and secretion (CIR).
Similar articles
- Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study.
Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE; Diabetes Prevention Program Research Group. Perreault L, et al. Lancet. 2012 Jun 16;379(9833):2243-51. doi: 10.1016/S0140-6736(12)60525-X. Epub 2012 Jun 9. Lancet. 2012. PMID: 22683134 Free PMC article. Clinical Trial. - Impact of Lifestyle and Metformin Interventions on the Risk of Progression to Diabetes and Regression to Normal Glucose Regulation in Overweight or Obese People With Impaired Glucose Regulation.
Herman WH, Pan Q, Edelstein SL, Mather KJ, Perreault L, Barrett-Connor E, Dabelea DM, Horton E, Kahn SE, Knowler WC, Lorenzo C, Pi-Sunyer X, Venditti E, Ye W; Diabetes Prevention Program Research Group. Herman WH, et al. Diabetes Care. 2017 Dec;40(12):1668-1677. doi: 10.2337/dc17-1116. Epub 2017 Oct 11. Diabetes Care. 2017. PMID: 29021207 Free PMC article. Clinical Trial. - Regression to Normal Glucose Regulation in American Indians and Alaska Natives of a Diabetes Prevention Program.
Pratte KA, Johnson A, Beals J, Bullock A, Manson SM, Jiang L; Special Diabetes Program for Indians Diabetes Prevention Program. Pratte KA, et al. Diabetes Care. 2019 Jul;42(7):1209-1216. doi: 10.2337/dc18-1964. Epub 2019 Jun 8. Diabetes Care. 2019. PMID: 31177184 Free PMC article. Clinical Trial. - Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus.
Hemmingsen B, Sonne DP, Metzendorf MI, Richter B. Hemmingsen B, et al. Cochrane Database Syst Rev. 2016 Oct 17;10(10):CD012151. doi: 10.1002/14651858.CD012151.pub2. Cochrane Database Syst Rev. 2016. PMID: 27749986 Free PMC article. Review.
Cited by
- Systemic nitric oxide metabolites and the chance of pre-diabetes regression to normoglycemia: A 9-year cohort study.
Bahadoran Z, Mirmiran P, Azizi F, Ghasemi A. Bahadoran Z, et al. Bioimpacts. 2024;14(5):29917. doi: 10.34172/bi.2024.29917. Epub 2024 Feb 14. Bioimpacts. 2024. PMID: 39296799 Free PMC article. - Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention.
Jumpertz von Schwartzenberg R, Vazquez Arreola E, Sandforth A, Hanson RL, Birkenfeld AL. Jumpertz von Schwartzenberg R, et al. Diabetologia. 2024 Aug;67(8):1714-1718. doi: 10.1007/s00125-024-06178-5. Epub 2024 May 23. Diabetologia. 2024. PMID: 38780785 Free PMC article. No abstract available. - Usual intake of dairy products and the chance of pre-diabetes regression to normal glycemia or progression to type 2 diabetes: a 9-year follow-up.
Bahadoran Z, Mirmiran P, Azizi F. Bahadoran Z, et al. Nutr Diabetes. 2024 Apr 9;14(1):15. doi: 10.1038/s41387-024-00257-7. Nutr Diabetes. 2024. PMID: 38594262 Free PMC article. - Association Between Monocyte-to-High-Density Lipoprotein Ratio and Prediabetes: A Cross-Sectional Study in Chinese Population.
Ruan C, Li Y, Ran Z, Liu G, Li W, Zhang X, Shao S, Li Y. Ruan C, et al. Diabetes Metab Syndr Obes. 2024 Mar 2;17:1093-1103. doi: 10.2147/DMSO.S451189. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38450416 Free PMC article. - Association between estimated glomerular filtration rate and reversion to normoglycemia in people with impaired fasting glucose: a 5-year retrospective cohort study.
Tu L, Hu H, Zhou X, Zhang H, Liu X, Yang D, He Y. Tu L, et al. Eur J Med Res. 2024 Feb 22;29(1):140. doi: 10.1186/s40001-024-01669-y. Eur J Med Res. 2024. PMID: 38388456 Free PMC article.
References
- Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76– 79 - PubMed
- Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R. The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 2003; 52: 1475– 1484 - PubMed
- Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343– 1350 - PubMed
- Buchanan TA, Xiang AH, Peters RK, Kjos SL, Marroquin A, Goico J, Ochoa C, Tan S, Berkowitz K, Hodis HN, Azen SP. Preservation of pancreatic β-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women. Diabetes 2002; 51: 2796– 2803 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical